AZ, Junshi Part Ways Amid China IO Commercial Struggle

 
• By Dexter Jie Yan
  
AZ the latest multinational pharma to opt out.
Multinationals start to opt out of tie-ups with Chinese immuno-oncology biotechs in packed domestic market • Source: Alamy

More from China

More from Focus On Asia